An extracellular protease of Streptococcus gordonii hydrolyzes type IV collagen and collagen analogues.
Streptococcus gordonii is a frequent cause of infective bacterial endocarditis, but its mechanisms of virulence are not well defined. In this study, streptococcal proteases were recovered from spent chemically defined medium (CDM) and fractionated by ammonium sulfate precipitation and by ion-exchange and gel filtration column chromatography. Three proteases were distinguished by their different solubilities in ammonium sulfate and their specificities for synthetic peptides. One of the enzymes cleaved collagen analogs Gly-Pro 4-methoxy-beta-naphthylamide, 2-furanacryloyl-Leu-Gly-Pro-Ala (FALGPA), and p-phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-Arg (pZ-peptide) and was released from the streptococci while complexed to peptidoglycan fragments. Treatment of this protease with mutanolysin reduced its 180- to 200-kDa mass to 98 kDa without loss of enzymatic activity. The purified protease cleaved bovine gelatin, human placental type IV collagen, and the Aalpha chain of fibrinogen but not albumin, fibronectin, laminin, or myosin. Enzyme activity was inhibited by phenylmethylsulfonyl fluoride, indicating that it is a serine-type protease. Maximum production of the 98-kDa protease occurred during growth of S. gordonii CH1 in CDM containing 0.075% total amino acids at pH 7.0 with minimal aeration. Higher initial concentrations of amino acids prevented the release of the protease without reducing cell-associated enzyme levels, and the addition of an amino acid mixture to an actively secreting culture stopped further enzyme release. The purified protease was stored frozen at -20 degreesC for several months or heated at 50 degreesC for 10 min without loss of activity. These data indicate that S. gordonii produces an extracellular gelatinase/type IV collagenase during growth in medium containing minimal concentrations of free amino acids. Thus, the extracellular enzyme is a potential virulence factor in the amino acid-stringent, thrombotic, valvular lesions of bacterial endocarditis.
Juarez
Z E
ZE
Center for Microbial Pathogenesis, School of Medicine and Biomedical Sciences, State University of New York at Buffalo 14214, USA.
Stinson
M W
MW
D000596:Amino Acids / Q000378:metabolism; D003094:Collagen / Q000031:analogs & derivatives / Q000378:metabolism*; D017077:Culture Media, Conditioned; D005110:Extracellular Space / Q000201:enzymology* / Q000382:microbiology; D006863:Hydrogen-Ion Concentration; D006868:Hydrolysis; D008970:Molecular Weight; D009842:Oligopeptides / Q000378:metabolism; D010457:Peptidoglycan / Q000378:metabolism; D012697:Serine Endopeptidases / Q000302:isolation & purification / Q000378:metabolism*; D013291:Streptococcus / Q000201:enzymology* / Q000254:growth & development; D013379:Substrate Specificity
D000596:Amino Acids; D017077:Culture Media, Conditioned; D009842:Oligopeptides; D010457:Peptidoglycan; C043091:PZ-peptide; C031821:2-furanacryloyl-leucyl-glycyl-prolyl-alanine; D003094:Collagen; D012697:Serine Endopeptidases